Advanced Medical Solutions Group Dirección
Dirección controles de criterios 4/4
El CEO de Advanced Medical Solutions Group es Chris Meredith , nombrado en Jan 2011, tiene una permanencia de 13.83 años. compensación anual total es £813.00K, compuesta por 46.6% salario y 53.4% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.83% de las acciones de la empresa, por valor de £3.72M. La antigüedad media del equipo directivo y de la junta directiva es de 4.8 años y 3.8 años, respectivamente.
Información clave
Chris Meredith
Chief Executive Officer (CEO)
UK£813.0k
Compensación total
| Porcentaje del salario del CEO | 46.6% |
| Permanencia del CEO | 13.8yrs |
| Participación del CEO | 0.8% |
| Permanencia media de la dirección | 4.8yrs |
| Promedio de permanencia en la Junta Directiva | 3.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Advanced Medical Solutions Group plc's (LON:AMS) Popularity With Investors Is Under Threat From Overpricing
Nov 18
A Look At The Fair Value Of Advanced Medical Solutions Group plc (LON:AMS)
Sep 07Should You Be Adding Advanced Medical Solutions Group (LON:AMS) To Your Watchlist Today?
Nov 03Advanced Medical Solutions Group plc (LON:AMS) Shares Could Be 38% Below Their Intrinsic Value Estimate
Sep 05Advanced Medical Solutions Group (LON:AMS) Will Want To Turn Around Its Return Trends
Dec 03Are Investors Undervaluing Advanced Medical Solutions Group plc (LON:AMS) By 23%?
Sep 03Advanced Medical Solutions Group's (LON:AMS) Returns On Capital Not Reflecting Well On The Business
Aug 05An Intrinsic Calculation For Advanced Medical Solutions Group plc (LON:AMS) Suggests It's 33% Undervalued
May 31Advanced Medical Solutions Group (LON:AMS) May Have Issues Allocating Its Capital
Apr 23Advanced Medical Solutions Group (LON:AMS) Might Be Having Difficulty Using Its Capital Effectively
Jan 08A Look At The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)
Nov 24Some Investors May Be Worried About Advanced Medical Solutions Group's (LON:AMS) Returns On Capital
May 22A Look At The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)
Apr 10Results: Advanced Medical Solutions Group plc Exceeded Expectations And The Consensus Has Updated Its Estimates
Mar 20Should Advanced Medical Solutions Group (LON:AMS) Be Disappointed With Their 30% Profit?
Feb 28The Returns At Advanced Medical Solutions Group (LON:AMS) Provide Us With Signs Of What's To Come
Feb 07
Advanced Medical Solutions Group plc's (LON:AMS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Jan 18How Much Is Advanced Medical Solutions Group plc (LON:AMS) Paying Its CEO?
Dec 28Calculating The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)
Dec 10The Advanced Medical Solutions Group (LON:AMS) Share Price Is Up 38% And Shareholders Are Holding On
Nov 20Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | UK£11m |
| Mar 31 2024 | n/a | n/a | UK£14m |
| Dec 31 2023 | UK£813k | UK£379k | UK£16m |
| Sep 30 2023 | n/a | n/a | UK£18m |
| Jun 30 2023 | n/a | n/a | UK£20m |
| Mar 31 2023 | n/a | n/a | UK£20m |
| Dec 31 2022 | UK£832k | UK£339k | UK£20m |
| Sep 30 2022 | n/a | n/a | UK£19m |
| Jun 30 2022 | n/a | n/a | UK£18m |
| Mar 31 2022 | n/a | n/a | UK£18m |
| Dec 31 2021 | UK£543k | UK£329k | UK£17m |
| Sep 30 2021 | n/a | n/a | UK£16m |
| Jun 30 2021 | n/a | n/a | UK£14m |
| Mar 31 2021 | n/a | n/a | UK£11m |
| Dec 31 2020 | UK£537k | UK£305k | UK£9m |
| Sep 30 2020 | n/a | n/a | UK£11m |
| Jun 30 2020 | n/a | n/a | UK£14m |
| Mar 31 2020 | n/a | n/a | UK£16m |
| Dec 31 2019 | UK£770k | UK£300k | UK£19m |
| Sep 30 2019 | n/a | n/a | UK£20m |
| Jun 30 2019 | n/a | n/a | UK£21m |
| Mar 31 2019 | n/a | n/a | UK£22m |
| Jan 01 2019 | n/a | n/a | UK£22m |
| Sep 30 2018 | n/a | n/a | UK£22m |
| Jun 30 2018 | n/a | n/a | UK£22m |
| Mar 31 2018 | n/a | n/a | UK£21m |
| Dec 31 2017 | UK£1m | UK£270k | UK£20m |
Compensación vs. Mercado: La compensación total ($USD1.02M) de Chris está en línea con el promedio de empresas de tamaño similar en el mercado UK ($USD988.12K).
Compensación vs. Ingresos: La compensación de Chris ha sido consistente con los resultados de la empresa en el último año.
CEO
Chris Meredith (58 yo)
13.8yrs
Permanencia
UK£813,000
Compensación
Mr. Andrew Christopher Meredith, also known as Chris, B.Sc. (Hons.) has been the Chief Executive Officer of Advanced Medical Solutions Group plc since January 2011 and served as Chief Operating Officer sin...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Executive Director | 13.8yrs | UK£813.00k | 0.83% £ 3.7m | |
| CFO & Executive Director | 5.8yrs | UK£415.00k | 0.078% £ 347.1k | |
| Group Operations Director | less than a year | sin datos | sin datos | |
| Investor Relations Manager | no data | sin datos | sin datos | |
| Head of Legal | no data | sin datos | sin datos | |
| Group Human Resources Director | 7.5yrs | sin datos | sin datos | |
| Chief Commercial Officer | less than a year | sin datos | sin datos | |
| Company Secretary | 3.8yrs | sin datos | sin datos |
4.8yrs
Permanencia media
Equipo directivo experimentado: El equipo directivo de AMS se considera experimentado (4.8 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Executive Director | 18.6yrs | UK£813.00k | 0.83% £ 3.7m | |
| CFO & Executive Director | 5.8yrs | UK£415.00k | 0.078% £ 347.1k | |
| Senior Independent Non-Executive Director | 3.8yrs | UK£57.00k | sin datos | |
| Independent Non-Executive Director | 3.3yrs | UK£54.00k | sin datos | |
| Independent Non-Executive Chairman | 2.3yrs | UK£46.00k | 0.025% £ 112.1k |
3.8yrs
Permanencia media
58yo
Promedio de edad
Junta con experiencia: La junta directiva de AMS se considera experimentada (3.8 años de antigüedad promedio).